Kezar Life Sciences

-$0.12 (-2.38%) Today
-$0.03 (-0.61%) As of 8:55 PM UTC after-hours

Why Robinhood?

You can buy or sell KZR and other stocks, options, and ETFs commission-free!

About KZR

Kezar Life Sciences, Inc. Common Stock, also called Kezar Life Sciences, is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California.

CEO
John Fowler
Employees
47
Headquarters
South San Francisco, California
Founded
2015

KZR Key Statistics

Market Cap
254.29M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
475.32K
High Today
$5.13
Low Today
$4.90
Open Price
$5.04
Volume
86.50K
52 Week High
$9.79
52 Week Low
$4.24

KZR Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, After Hours

You May Also Like

IMPX+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure